WOW !! MUCH LOVE ! SO WORLD PEACE !
Fond bitcoin pour l'amélioration du site: 1memzGeKS7CB3ECNkzSn2qHwxU6NZoJ8o
  Dogecoin (tips/pourboires): DCLoo9Dd4qECqpMLurdgGnaoqbftj16Nvp


Home | Publier un mémoire | Une page au hasard

 > 

La lipoprotéine Lp(a):son intérêt dans l'interprétation du bilan lipidique

( Télécharger le fichier original )
par Marie- Christine Guimont
Université Paris V - Docteur d'état en pharmacie 1998
  

précédent sommaire suivant

Bitcoin is a swarm of cyber hornets serving the goddess of wisdom, feeding on the fire of truth, exponentially growing ever smarter, faster, and stronger behind a wall of encrypted energy

J. Lipid Res. 1985, 26, 267-269

293 GUO H., ARMSTRONG V., LUC G., BILLARDON C., GOULINET S.,et al.

Characterization of five mouse monoclonal antibodies to apolipoprotein(a) from human Lp(a) : evidence for weak plasminogen reactivity.

J. Lipid Res. 1989, 30, 23-37

Thèse Docteur Pharmacie La lipoprotéine Lp(a) : son intérêt dans l'interprétation du bilan lipidique Dr GUIMONT MC 262/271 Lipides, Lipoprotéine (a), Hyperlipoprotéinémie, Athérosclérose, Lipids, Lipoprotein, Lpa, Hyperlipoproteinemia, Atherosclerosis

294 MARCOVINA S., ALBERS J., GABEL B., KOSCHINSKY M., GAUR V.

Effect of the number of apolipoprotein(a) kringle 4 domains on immunochemical measurements of lipoprotein(a).

Clin. Chem. 1995, 41, 246-255

295 MARCOVINA S., ALBERS J. et al.

International Federation of Clinical Chemistry standardization project for measurements of Apolipoprotein A-1 and B. IV. Comparability of apolipoproteinB values by use of international reference material.

Clin. Chem. 1994, 40, 586-592

296 FLESS G., SNYDER M., SCANU A. Enzyme-linked immunoassay for Lp(a). J. Lipid Res. 1989, 30, 651-662

297 ALBERS J.J., MARCOVINA S..

Lipoprotein(a) quantification: comparison of methods and strategies for standardization.

Curr. Opin. Lipidol. 1994, 5, 417-421

298 CRAIG W., LEDUE T.

The effects of long term storage on serum Lp(a) levels. Atherosclerosis 1992, 93, 261 (Letter).

299 NAUCK M., WINKLER K., WITTMANN C., MAYER H., LULEY C. et al.

Direct determination of lipoprotein(a) cholesterol by ultracentrifugation and agarose gel electrophoresis with enzymatic staining for cholesterol.

Clin. Chem. 1995, 41, 731-738

308 SEMAN L., JENNER J., Mc NAMARA J., SCHAEFER E.

Quantification of lipoprotein(a) in plasma by assaying cholestérol in lectin-bound plasma fraction. Clin. Chem. 1994, 40, 400-403

301 MARCOVINA S., GAUR V., ALBERS J.

Biological variability of cholesterol, triglyceride, low- and high density lipoprotein cholesterol, lipoprotein(a), and apolipoproteins A-1 and B.

Clin. Chem. 1994, 40, 574-578

302 KRONENBERG F., UTERMANN G., DIEPLINGER H. Lipoprotein(a) in renal disease.

Amer. J. Kidney Diseases 1996, 27, 1-25.

303 RUMEAU-ROUQUETTE C. Méthodes en épidémiologie Flammarion.

304 DAHLEN G.H., ERICSON C., FURBERG C., LUNDKVIST L., SVARSUDD K. Angina of effort and an extra pre-beta lipoprotein fraction.

Acta Med. Scand. 1972, 531, 25

305 DAHLEN G. BERG K., RAMBERG U., TAMM A. Lp(a) lipoprotein and pre-01-lipoprotein in young adults. Acta Med. Scand. 1974, 196, 327-331

306 KOSTNER G., AVOGARO P., CAZZOLATO G., MARTH E., BITTOLO-BON G., QUNICI G. Lipoprotein Lp(a) and the risk for myocardial infaction.

Atherosclerosis 1981, 38, 51-61

307 RHOADS G., DAHLEN G., BERG K., MORTON N., DANNENBERG A. Lp(a) lipoprotein as a risk factor for myocardial infarction.

JAMA 1986, 256, 2540-2544

Thèse Docteur Pharmacie La lipoprotéine Lp(a) : son intérêt dans l'interprétation du bilan lipidique Dr GUIMONT MC 263/271 Lipides, Lipoprotéine (a), Hyperlipoprotéinémie, Athérosclérose, Lipids, Lipoprotein, Lpa, Hyperlipoproteinemia, Atherosclerosis

308 ARMSTRONG V., CREMER P., EBERLE E., MANKE A., SCHULZE F. et al

The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis. Dependance on serum LDL levels.

Atherosclerosis 1986, 62, 249-257

306 SANDKAMP M., FUNKE H., SCHUTE H., KHOLER E., ASSMANN G.

Lipoprotei(a) is an independent risk factor for myocardial infarction at young age. Clin. Chem. 1990, 36, 20-23

310 GENEST J. JENNER J., McNAMARA J., ORDOVAS J., SILBERMAN S. et al Prevalence of lipoprotein(a) exess in coronary artery disease.

Am. J. Cardiol. 1991, 67,

311 SANDHOLZER C., BOERWINKLE E., SAHA N., TONG M.C., UTERMANN G.

Apolipoprotein(a) phenotypes, Lp(a) concentration and plasma lipid levels in relation to coronary heart disease in a chinese population. Evidence for the role of the apo(a) gene in coronary heart disease. J. Clin. Inves. 1992, 89, 1040-1046

312 GENEST J., JENNER J., Mc NAMARA J., ORDOVAS J., SILBERMAN S. et al

Lipoprotein cholesterol, apolipoprotein A-1 and B and lipoprotein(a) abnormalities in men with premature coronary artery disease.

précédent sommaire suivant






Bitcoin is a swarm of cyber hornets serving the goddess of wisdom, feeding on the fire of truth, exponentially growing ever smarter, faster, and stronger behind a wall of encrypted energy








"En amour, en art, en politique, il faut nous arranger pour que notre légèreté pèse lourd dans la balance."   Sacha Guitry